Neurogene (NGNE) Earnings Analysis
Neurogene (NGNE) next reports earnings on 2026-08-10, consensus EPS -1.4 USD. Last quarter (2026-03-24) it beat with EPS -1.12 USD vs -1.23875 USD est (+9.6%). It has beaten estimates in 5/7 recent quarters (71%). Trailing P/E -7.18.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does NGNE next report earnings?
| Next earnings date | 2026-08-10 |
|---|---|
| Consensus EPS estimate | -1.4 USD |
| Revenue estimate | n/a |
NGNE earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-24 | -1.12 USD | -1.23875 USD | +9.6% | Beat |
| 2025-11-13 | -0.99 USD | -1.26 USD | +21.4% | Beat |
| 2025-08-11 | -1.05 USD | -1.15 USD | +8.7% | Beat |
| 2025-05-09 | -1.08 USD | -1.05 USD | -2.9% | Miss |
| 2025-03-24 | -0.99 USD | -1.04 USD | +4.8% | Beat |
| 2024-11-18 | -1.19 USD | -1.22 USD | +2.5% | Beat |
| 2024-08-09 | -1.09 USD | -1.02 USD | -6.9% | Miss |
Beat rate: 5/7 (71%) over reported quarters with consensus data.
NGNE valuation and analyst view
| Trailing P/E | -7.18 |
|---|---|
| Trailing EPS | -4.42209 USD |
| Price / book | 3.39 |
| Dividend yield | 0.00% |
| Market cap | 0.57B |
| Analyst consensus | Buy (5 buy / 1 hold / 0 sell) |
| Avg price target | 69.67 USD |
Related research pages
Frequently asked questions
When is Neurogene (NGNE)'s next earnings date?
Neurogene is next scheduled to report on 2026-08-10, with a consensus EPS estimate of -1.4 USD.
Did NGNE beat earnings last quarter?
In its 2026-03-24 report, NGNE posted EPS of -1.12 USD versus a -1.23875 USD estimate — a beat of 9.6%.
What is NGNE's earnings track record?
Over the last 7 reported quarters with consensus data, NGNE beat estimates 5 times (71%).
What is NGNE's current P/E ratio and EPS?
NGNE trades at a trailing P/E of -7.18 on trailing EPS of -4.422091646928095 USD.
What do analysts rate NGNE?
Analyst consensus is "Buy" across 6 ratings (0 strong buy, 5 buy, 1 hold, 0 sell, 0 strong sell). Average 12-month price target: 69.67 USD.